Status:
COMPLETED
Perioperative Care in the Cancer Patient -1, ARCA-1 Study
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm
Eligibility:
All Genders
18+ years
Brief Summary
This study investigates the association of blood transfusions given around the time of surgery (perioperative) with complications after surgery (postoperative), cancer progression, and mortality after...
Detailed Description
PRIMARY OBJECTIVE: I. To evaluate if perioperative blood transfusions are associated with 1-year mortality. SECONDARY OBJECTIVES: I. To evaluate the association of blood transfusion with postoperat...
Eligibility Criteria
Inclusion
- Patient undergoing major cancer surgery with curative intent
- Planned length of stay 24 hours after surgery or longer
- American Society of Anesthesiologists physical status (ASA) 1-4
- Scheduled, non-emergency surgery
Exclusion
- Emergency surgery
- Palliative surgeries for metastatic disease (non-curative intent)
- Patients undergoing surgery with minimum risk (\< 1%) of blood transfusion according to each center practice (i.e. simple mastectomy, thyroidectomies or wide-local excisions)
- Patients undergoing surgery under local anesthesia
- Patients undergoing ambulatory surgery or planned hospital admission of less than 24 hours
Key Trial Info
Start Date :
August 3 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 17 2023
Estimated Enrollment :
229 Patients enrolled
Trial Details
Trial ID
NCT04491409
Start Date
August 3 2020
End Date
November 17 2023
Last Update
November 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030